Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

NewsGuard 100/100 Score

Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and periodic fever syndrome. Using the drug Colchicine, researchers saw rapid improvement not only in their fevers but also with other long COVID symptoms such as brain fog, fatigue, and achiness. The case study was just published in Journal of Allergy and Clinical Immunology, (JACI: In Practice).

Long COVID is defined as persistent symptoms lasting greater than twelve weeks after the initial illness. A previous analysis of pediatric patients observed 25% of patients experiencing long COVID symptoms. Symptoms include fatigue, headache, dizziness, dyspnea, chest pain, reduced appetite, concentration difficulties, memory issues, mental exhaustion, physical exhaustion and sleep issues. In addition to these common symptoms, recurrent fevers are reported in approximately 2% of pediatric patients with long COVID.

For this case study, researchers evaluated two adolescent patients suffering long COVID symptoms, including recurring fever. They found through genetic testing that both individuals had a pathogenic heterozygous mutation in the innate immunity regulator pyrin: MEFV gene. Mutations in MEFV have been identified with periodic fever syndromes, and Colchicine therapy has shown previously effective in those suffering from the condition.

So much about the cause and treatment for symptoms from long COVID remains unknown. This case report is helpful in identifying a subset of pediatric long COVID patients who respond well to a safe and well-described treatment. Children with persistent recurrent fevers after COVID-19 infection should be tested for this genetic variant."

Nathan Rabinovitch, MD, MPH, director of the pediatric care unit at National Jewish Health and senior author of the study

Recurrent fevers are seen in pediatric diseases such as familial Mediterranean fever and periodic fever with aphthous stomatitis, pharyngitis and adenitis. Both diseases are associated with changes in a gene that controls a fever-regulating protein called pyrin.

"Once we saw the gene mutation in both children, Colchicine therapy was initiated for both patients and resulted in near immediate resolution of fevers and improvement in other symptoms," said Dr. Rabinovitch.

Source:
Journal reference:

Keller, L., & Rabinovitch, N. (2023). Post COVID Recurrent Fever in Children with Polymorphisms in the Innate Immunity Regulator, Pyrin; MEFV Gene. The Journal of Allergy and Clinical Immunology: In Practice. doi.org/10.1016/j.jaip.2023.02.036.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single measles jab up to 2.6 times more likely to be ineffective in C-section born children